Local treatment with the selective IκB kinase β inhibitor NEMO-binding domain peptide ameliorates synovial inflammation
Sander W. Tas(Amsterdam University Medical Centers), Paul P. Tak(Celldex Therapeutics (United States))
Cited by 74
Related Papers
NF-κB: a key role in inflammatory diseases
|Journal of Clinical Investigation|2001|3.9k
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
|Pharmacology & Therapeutics|2007|1.6k
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci
|Nature Genetics|2010|1.3k
Common variants at CD40 and other loci confer risk of rheumatoid arthritis
|Nature Genetics|2008|542
Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis
|Annals of the Rheumatic Diseases|2004|464